RAD51 and Familial prostate cancer: BRCA2 mutations are known to be associated with a higher prostate cancer mortality, likely due to the direct involvement of BRCA2 in the homologous recombination process, as it mediates the recruitment of RAD51 to DNA double-strand breaks [61].